Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02220608. IPD Sharing: NO. Countries: 1. Publications: 1.
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05363111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
ClinicalTrials.gov study NCT00760370. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02462525. IPD Sharing: UNDECIDED. Countries: 4. Publications: 1.
NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
ClinicalTrials.gov study NCT03169361. IPD Sharing: YES. Countries: 1. Publications: 0.
T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
ClinicalTrials.gov study NCT00048464. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study of bb2121 in Multiple Myeloma
ClinicalTrials.gov study NCT02658929. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab "
ClinicalTrials.gov study NCT02419118. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma
ClinicalTrials.gov study NCT03023527. IPD Sharing: NO. Countries: 1. Publications: 10.
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT00057564. IPD Sharing: Not stated. Countries: 16. Publications: 1.
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
ClinicalTrials.gov study NCT04920084. IPD Sharing: YES. Countries: 1. Publications: 0.
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
ClinicalTrials.gov study NCT04309084. IPD Sharing: NO. Countries: 1. Publications: 1.
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
ClinicalTrials.gov study NCT00881920. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02219178. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma
ClinicalTrials.gov study NCT00004088. IPD Sharing: NO. Countries: 1. Publications: 0.
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
ClinicalTrials.gov study NCT03441958. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT05759793. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma
ClinicalTrials.gov study NCT03848676. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00193557. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
ClinicalTrials.gov study NCT00079716. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.